This study is looking at whether oxytocin can help prevent heavy bleeding (hemorrhage) during a second-trimester dilation and evacuation (D&E) procedure. You would receive either oxytocin mixed with normal saline, or normal saline alone, through an IV. Researchers will compare these two groups to see if oxytocin reduces the amount of blood loss and the rate of hemorrhage on the day of the procedure. This study is for women aged 18 to 55 who are having a D&E at 18 weeks or more of pregnancy and can speak English or Spanish. You cannot join if you refuse an IV, have certain blood clotting issues, or other specific medical conditions. The study is currently recruiting 150 participants.

Study design

This is an interventional study comparing two groups: one receiving oxytocin and one receiving normal saline. It plans to enroll 150 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Hemorrhage and quantitative blood loss are measured on the day of the procedure.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.